Yd. Zhao et al., LOCALIZATION AND CHARACTERIZATION OF ENDOTHELIN-1 RECEPTOR-BINDING INTHE BLOOD-VESSELS OF HUMAN PULMONARY TUMORS, Journal of cardiovascular pharmacology, 26, 1995, pp. 341-345
We have demonstrated endothelin-1 (ET-1) binding sites in the blood ve
ssels of human pulmonary tumors by in vitro autoradiography. The blood
vessels of the tumors were confirmed by immunostaining with von Wille
brand factor. Specific [I-125]ET-1 binding was identified in the blood
vessels of all sizes in both tumor and stromal tissues. Nonspecific b
inding was observed in squamous cell carcinomas and in carcinoids. The
ET-1 binding in blood vessels was specific, saturable, and time-depen
dent. The binding reached equilibrium at 120 min. Scatchard analysis o
f [I-125]ET-1 binding to sections of blood vessels of squamous cell ca
rcinoma indicated binding to a single class of binding sites, with a d
issociation constant (K-d) of 0.16 nM and a maximal density of binding
sites (B-max) of 126 amol/mm(2). The binding was competitively inhibi
ted by ET-1 much greater than VIC > ET-2 > sarafotoxin (SRb) > ET-3 bu
t not by other unrelated peptides. Our results provide evidence that E
T-1 binding is localized in the blood vessels of pulmonary tumors and
in stromal tissues surrounding the tumor nest. ET may play a role in t
he angiogenesis of tumor growth.